A Chronic Respiratory <i>Pasteurella multocida</i> Infection Is Well-Controlled by Long-Term Macrolide Therapy

Access this Article

Search this Article

Author(s)

    • Seki Masafumi
    • Division of Infection Control and Prevention, Osaka University Hospital, Japan
    • Sakata Tomomi
    • Laboratory for Clinical Investigation, Osaka University Hospital, Japan
    • Nishi Isao
    • Laboratory for Clinical Investigation, Osaka University Hospital, Japan
    • Tomono Kazunori
    • Division of Infection Control and Prevention, Osaka University Hospital, Japan

Abstract

A 57-year-old woman with severe bronchiectasis frequently received antibiotics, including penicillin, for acute exacerbations due to <i>Pasteurella multocida</i>. Although the bacteria showed a decrease in antibiotic susceptibility, her symptoms and X-ray findings became stable, and severe exacerbations were not observed for the last few years after a low-dose erythromycin treatment was started. The development of a respiratory infection with <i>Pasteurella multocida</i> is relatively uncommon, but it can be controlled by immunomodulation which is associated with long-term macrolide therapy.<br>

Journal

  • Internal Medicine

    Internal Medicine 55(3), 307-310, 2016

    The Japanese Society of Internal Medicine

Codes

Page Top